Fonar Corporation(FONR)
USD --+0.00%
Reward41Moderate
Risk33Moderate
📊75%Data
FONR
+0.0 · +0.00%
USD · NASDAQ
Fonar Corporation | Healthcare
Value Trap
Market Cap:92.74M
ℹ️
Reward Rating
41
Moderate
Bottom 10% (model universe)
75% data coverage
ℹ️
Risk Rating
33
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on FONR to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Fonar Corporation?

FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States.

FONR · Verdict

Moderate reward · moderate risk

FONR stands out on balance sheet and valuation, but watch the growth signal.

Based on 88% data coverage

FONR · Verdict

What’s working & what to watch

Strengths 2

  • Balance sheet99/100

    Interest covered 452.9×

  • Valuation70/100

    Above average

Watchouts 1

  • Growth21/100

    Rev +2.3% CAGR · earnings -12.5%

Model-based scoring. For information only — not financial advice.

What is Fonar Corporation?

FONAR Corporation, together with its subsidiaries, engages in the designing, manufacturing, selling, and servicing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases, abnormalities, other medical conditions, and injuries in the United States. It operates in two segments: Medical Equipment, and Physician Management and Diagnostic Services. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 92.74M, and a P/E ratio of 13.3x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Profitability metrics are mixed — margins may be under pressure.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Currently trading below intrinsic value estimates, suggesting upside potential.

OpenBook Logo Analysis

Reward: Moderate (41)

The scoring profile indicates limited reward potential at this time, with valuation and momentum offering the most support. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap92.74M
P/E Ratio13.2703
Dividend YieldN/A
52 Week High18.86
52 Week Low12
Last AnnualJune
IPO Date1/1/1987
IncorporatedUSA
Shares Outstanding6M
No. of Employees535
IndustryDiagnostics & Research
ExchangeNASDAQ
Beta0.989
CurrencyUSD